Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Genomic characterization of spleens in patients with myelofibrosis.

Literature DB >> 29748436

Genomic characterization of spleens in patients with myelofibrosis.

Eran Zimran¹, Joseph Tripodi^1,2, Raajit Rampal³, Franck Rappoport^3,4, Sharon Zirkiev², Ronald Hoffman¹, Vesna Najfeld^5,2.

Abstract

Entities: Disease Species

Mesh：

Year: 2018 PMID： 29748436 PMCID： PMC6165826 DOI： 10.3324/haematol.2018.193763

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

× No keyword cloud information.

15 in total

1. TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia.

Authors: Li Yao; Jiannong Cen; Jinlan Pan; Dandan Liu; Yong Wang; Zixing Chen; Changgeng Ruan; Suning Chen
Journal: Cancer Genet Date: 2017-01-10

2. Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.

Authors: Nicole Kucine; Aaron D Viny; Raajit Rampal; Michael Berger; Nicholas Socci; Agnes Viale; James B Bussel; Ross L Levine; Franck Rapaport
Journal: Haematologica Date: 2016-03-18 Impact factor: 9.941

3. Continued Role of Splenectomy in the Management of Patients With Myelofibrosis.

Authors: Daniel Aruch; Myron Schwartz; John Mascarenhas; Marina Kremyanskaya; Carrie Newsom; Ronald Hoffman
Journal: Clin Lymphoma Myeloma Leuk Date: 2016-06-08

Review 4. Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack.

Authors: Oscar Krijgsman; Beatriz Carvalho; Gerrit A Meijer; Renske D M Steenbergen; Bauke Ylstra
Journal: Biochim Biophys Acta Date: 2014-08-07

5. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.

Authors: R A Mesa; C Y Li; G Schroeder; A Tefferi
Journal: Blood Date: 2001-06-01 Impact factor: 22.113

Review 6. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.

Authors: William Vainchenker; Robert Kralovics
Journal: Blood Date: 2016-12-27 Impact factor: 22.113

7. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.

Authors: Sergej Konoplev; Pin-Pen Hsieh; Chung-Che Chang; L Jeffrey Medeiros; Pei Lin
Journal: Hum Pathol Date: 2007-08-20 Impact factor: 3.466

8. The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

Authors: Pin-Pen Hsieh; Randy J Olsen; Dennis P O'Malley; Sergej N Konoplev; Jerry W Hussong; Cherie H Dunphy; Sherrie L Perkins; Liang Cheng; Pei Lin; Chung-Che Chang
Journal: Mod Pathol Date: 2007-07-20 Impact factor: 7.842

Genomic characterization of spleens in patients with myelofibrosis.

1. TAF15-ZNF384 fusion gene in childhood mixed phenotype acute leukemia.

2. Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.

3. Continued Role of Splenectomy in the Management of Patients With Myelofibrosis.

Review 4. Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack.

5. Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.

Review 6. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms.

7. Janus kinase 2 V617F mutation is detectable in spleen of patients with chronic myeloproliferative diseases suggesting a malignant nature of splenic extramedullary hematopoiesis.

8. The role of Janus Kinase 2 V617F mutation in extramedullary hematopoiesis of the spleen in neoplastic myeloid disorders.

9. Rasa3 controls megakaryocyte Rap1 activation, integrin signaling and differentiation into proplatelet.

10. Rescue of a primary myelofibrosis model by retinoid-antagonist therapy.

1. Advanced forms of MPNs are accompanied by chromosomal abnormalities that lead to dysregulation of TP53.

Review 2. How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation.